Extending letrozole treatment to 10 years may prevent recurrent breast cancer
Metadata[+] Show full item record
Bottom line: Extension of letrozole therapy to 10 years reduces disease recurrence and occurrence of contralateral breast cancer, but does not affect overall mortality.Review and summary of: Goss PE, Ingle JN, Pritchard KI, et al. Extending aromatase-inhibitor adjuvant therapy to 10 years. N Engl J Med. 2016; 375(3):209-219.
Evidence-based practice 20, no. 5 (2017): 04